BR Biopharma, Inc. (NASDAQ:BRBI) Sees Significant Increase in Short Interest

Posted by on Sep 2nd, 2026

BR Biopharma, Inc. (NASDAQ:BRBI – Get Free Report) was the target of a large growth in short interest in August. As of August 14th, there was short interest totaling 3,543 shares, a growth of 50.9% from the July 30th total of 2,348 shares. Based on an average daily volume of 742 shares, the days-to-cover ratio is currently 4.8 days. Approximately 0.0% of the company’s stock are sold short.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

View Our Latest Stock Analysis on BRBI

Institutional Investors Weigh In On BR Biopharma

An institutional investor recently bought a new position in BR Biopharma stock. Acuitas Investments LLC acquired a new stake in BR Biopharma, Inc. (NASDAQ:BRBI – Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma makes up approximately 3.2% of Acuitas Investments LLC’s investment portfolio, making the stock its 7th biggest holding.

BR Biopharma Trading Up 9.1%

Shares of NASDAQ BRBI opened at $10.82 on Wednesday. The business’s fifty day moving average is $10.83. BR Biopharma has a 1-year low of $9.09 and a 1-year high of $67.01. The firm has a market capitalization of $127.78 million and a P/E ratio of 135.25.

BR Biopharma (NASDAQ:BRBI – Get Free Report) last announced its quarterly earnings data on Tuesday, June 30th. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $25.13 million during the quarter.

BR Biopharma Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Monday, August 17th will be paid a dividend of $0.1415 per share. This represents a $0.57 dividend on an annualized basis and a dividend yield of 5.2%. The ex-dividend date is Monday, August 17th. BR Biopharma’s payout ratio is 525.00%.

About BR Biopharma

(Get Free Report)

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.

Featured Stories

Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.